Anakinra in Patients With Systemic Juvenile Idiopathic Arthritis: Long-term Safety From the Pharmachild Registry. Giancane G, Papa R, Vastert S, Bagnasco F, et al. J Rheumatol 2022;49:398-407.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Giancane G, Papa R, Vastert S, Bagnasco F, et al. Anakinra in Patients With Systemic Juvenile Idiopathic Arthritis: Long-term Safety From the Pharmachild Registry. J Rheumatol 2022;49:398-407.
PMID: 35105709